Last reviewed · How we verify

Continuous sciatic nerve block

Universidad de Antioquia · Phase 3 active Small molecule

A continuous sciatic nerve block delivers local anesthetic medication directly to the sciatic nerve over an extended period to provide prolonged pain relief and sensory blockade in the lower extremity.

A continuous sciatic nerve block delivers local anesthetic medication directly to the sciatic nerve over an extended period to provide prolonged pain relief and sensory blockade in the lower extremity. Used for Postoperative pain management following lower extremity surgery, Acute pain relief in lower extremity trauma or injury.

At a glance

Generic nameContinuous sciatic nerve block
Also known asPeriferical continuous block
SponsorUniversidad de Antioquia
ModalitySmall molecule
Therapeutic areaPain Management / Regional Anesthesia
PhasePhase 3

Mechanism of action

This is a regional anesthesia technique that uses a catheter placed near the sciatic nerve to continuously infuse local anesthetic agents, blocking pain signals from the lower leg and foot. The continuous delivery allows for sustained analgesia beyond single-injection nerve blocks, reducing the need for systemic opioids and supporting multimodal pain management strategies.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: